Retinoic acid (RA) and As2O3 treatment in transgenic models of acute promyelocytic leukemia (APL) unravel the distinct nature of the leukemogenic process induced by the PML-RARalpha and PLZF-RARalpha oncoproteins
Proceedings of the National Academy of Sciences of the United States of America (2000) - Comments
pubmed: 10954752  doi: 10.1073/pnas.180290497  issn: 0027-8424  issn: 1091-6490 

E. M. Rego, L.-Z. He, R. P. Warrell, Z.-G. Wang, P. P. Pandolfi